FDA official logo
GSRS logoPFDA official logo

ATAGLOGENE AUTOGETEMCEL

UNII:X9AT6SDG44
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:ATAGLOGENE AUTOGETEMCEL
GSRS Full Record:

  • Ataglogene Autogetemcel
  • ataglogene autogetemcel [INN]
  • autologous CD34+ hematopoietic stem cells obtained by apheresis, electroporated with a multi-component CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9)-guide RNA (gRNA) transformer base editor nucleoprotein complex that targets the promoter regions of the two γ-globin genes (HBG1 and HBG2) to disrupt binding of the transcriptional repressor BCL11A (B-cell lymphoma/leukemia 11A), leading to the re-expression of γ-globin and increased production of foetal haemoglobin (HbF). The transformer base editing system comprises two mRNAs and two single guide RNAs. The first mRNA (mRNA-L) encodes an impaired form of the Streptococcus pyogenes clustered regularly interspaced short palindromic repeats (CRISPR) associated protein 9 and is referred to as Cas9 nickase D10A. The second mRNA (mRNA-EK) encodes three independent proteins, separated by 2A peptides; the first protein (MCP-UGI-mA3CDA1-mA3dCDI), is a fusion protein comprising (5' to 3') an RNA aptamer binding protein [bacteriophage MS2 coat protein (MCP)], a uracil DNA glycosylase inhibitor (UGI), the mouse apolipoprotein B mRNA-editing complex 3 (APOBEC3, mA3) cytidine deaminase domain 1 (mA3CDA1), a tobacco etch virus (TEV) protease cleavage site, and the mouse APOBEC3 deoxycytidine deaminase inhibitor domain (dCDI) (mA3dCDI). The second protein (N22p-TEVc) contains an RNA aptamer binding protein (bacteriophage N peptide 1-22) fused with the C-terminal fragment of the tobacco etch virus protease (TEVc). The third protein (TEVn) comprises the N-terminal fragment of the TEV protease. The first single guide RNA is a helper gRNA (hsgRNA) that guides nCas9 to the first target site and contains an MS2 hairpin to recruit the MCP-UGI-mA3CDA1-mA3dCDI fusion protein. The second sgRNA is a modifying gRNA (msgRNA) that guides a second nCas9 to the gene editing target site and contains box B hairpins to recruit the N22p-TEVc protein. When the two guide RNAs bind on-target, the two halves of the TEV protease (TEVn and TEVc) reconstitute, and the protease can cleave off the deoxycytidine deaminase inhibitor (mA3dCDI) from the mRNA editing cytidine deaminase domaine 1 (mA3CDA1) to edit the transcriptional repressor BCL11A binding domain of the γ-globin promoter regions. The apheresis material is enriched in CD34+ cells using immunomagnetic microbeads, gene-edited and then cultured in the presence of thrombopoietin (TPO), stem cell factor (SCF) and Fms-like tyrosine kinase 3 ligand (Flt-3L). The final substance contains ≥90% CD34+ cells and has a target gene editing efficiency of ≥30%



UNII - X9AT6SDG44 | UNII Search Service